Kristensen G - Search Results

1

Prospectively detected cancer in familial breast/ovarian cancer screening.

Dørum A, Heimdal K, Løvslett K, Kristensen G, Hansen LJ, Sandvei R, Schiefloe A, Hagen B, Himmelmann A, Jerve F, Shetelig K, Fjaerestad I, Tropé C, Møller P. Dørum A, et al. Among authors: kristensen g. Acta Obstet Gynecol Scand. 1999 Nov;78(10):906-11. Acta Obstet Gynecol Scand. 1999. PMID: 10577622

2

Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis.

Makar AP, Kristensen GB, Kaern J, Børmer OP, Abeler VM, Tropé CG. Makar AP, et al. Among authors: kristensen gb. Obstet Gynecol. 1992 Jun;79(6):1002-10. Obstet Gynecol. 1992. PMID: 1579296

3

CA 125 measured before second-look laparotomy is an independent prognostic factor for survival in patients with epithelial ovarian cancer.

Makar AP, Kristensen GB, Børmer OP, Tropé CG. Makar AP, et al. Among authors: kristensen gb. Gynecol Oncol. 1992 Jun;45(3):323-8. doi: 10.1016/0090-8258(92)90313-8. Gynecol Oncol. 1992. PMID: 1612511

4

The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma.

Nordal RR, Kristensen GB, Kaern J, Stenwig AE, Pettersen EO, Tropé CG. Nordal RR, et al. Among authors: kristensen gb. Acta Oncol. 1995;34(6):797-802. doi: 10.3109/02841869509127189. Acta Oncol. 1995. PMID: 7576748

5

[Preoperative identification of malignancy among women with a pelvic mass].

Tropé C, Kristensen G. Tropé C, et al. Among authors: kristensen g. Tidsskr Nor Laegeforen. 1995 Mar 10;115(7):812-3. Tidsskr Nor Laegeforen. 1995. PMID: 7701484 Norwegian. No abstract available.

6

No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients.

Kristensen GB, Kaern J, Abeler VM, Hagmar B, Tropé CG, Pettersen EO. Kristensen GB, et al. Gynecol Oncol. 1995 Apr;57(1):79-85. doi: 10.1006/gyno.1995.1102. Gynecol Oncol. 1995. PMID: 7705705

7

Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients.

Scheistrøen M, Tropé C, Koern J, Pettersen EO, Abeler VM, Kristensen GB. Scheistrøen M, et al. Among authors: kristensen gb. Cancer. 1995 Jan 1;75(1):72-80. doi: 10.1002/1097-0142(19950101)75:1<72::aid-cncr2820750113>3.0.co;2-g. Cancer. 1995. PMID: 7804980

8

A randomised study of cisplatin versus thiotepa as induction chemotherapy in advanced ovarian carcinoma.

Dørum A, Kristensen GB, Tropé C. Dørum A, et al. Among authors: kristensen gb. Eur J Cancer. 1994;30A(10):1470-4. doi: 10.1016/0959-8049(94)00240-6. Eur J Cancer. 1994. PMID: 7833104 Clinical Trial.

9

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer.

Makar AP, Baekelandt M, Tropé CG, Kristensen GB. Makar AP, et al. Among authors: kristensen gb. Gynecol Oncol. 1995 Feb;56(2):175-80. doi: 10.1006/gyno.1995.1027. Gynecol Oncol. 1995. PMID: 7896181

10

Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.

Kaern J, Tropé CG, Kristensen GB, Tveit KM, Pettersen EO. Kaern J, et al. Among authors: kristensen gb. Am J Obstet Gynecol. 1994 Feb;170(2):479-87. doi: 10.1016/s0002-9378(94)70215-2. Am J Obstet Gynecol. 1994. PMID: 8116701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

371 results

Search Page

Filters